Detalhe da pesquisa
1.
Consolidation of a Molecular Signature of Healing in Cutaneous Leishmaniasis Is Achieved during the First 10 Days of Treatment.
J Immunol
; 212(5): 894-903, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38231122
2.
Immuno-pharmacokinetics of Meglumine Antimoniate in Patients With Cutaneous Leishmaniasis Caused by Leishmania (Viannia).
Clin Infect Dis
; 72(10): e484-e492, 2021 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32818964
3.
Phenotypic and functional stability of leukocytes from human peripheral blood samples: considerations for the design of immunological studies.
BMC Immunol
; 20(1): 5, 2019 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30658588
4.
Innate biosignature of treatment failure in human cutaneous leishmaniasis.
Res Sq
; 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38746226
5.
Quality parameters for RNA preparations from biopsies of ulcerated human skin.
Wellcome Open Res
; 7: 249, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36879918
6.
Inductively coupled plasma mass spectrometry method for plasma and intracellular antimony quantification applied to pharmacokinetics of meglumine antimoniate.
Bioanalysis
; 13(8): 655-667, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33829863
7.
Comparative Assessment of DNA Targets and Amplification Methods for Leishmania (Viannia) Detection in Human Samples.
Am J Trop Med Hyg
; 102(6): 1323-1327, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32228793